We Salvavidas Pharmaceutical Pvt Ltd are a leading Manufacturer and Exporter of Aprepetant capsule in different strength and packing. Our manufacturing facility is certified with WHO-GMP.
We are among the prominent manufacturers, suppliers, traders and exporters of optimum quality Aprepitant Capsules. The offered medicines are used for preventing nausea and vomiting for patients undergoing chemotherapy. Due to their fast results and high effectiveness, these drugs are highly demanded.
Composition : Aprepetant capsule 125 mg (1 capsule) 80 mg (2 capsules)

Features:

• High bio availability
• Long shelf life
• Fast results
• High effectiveness

Indication: Aprecap is also indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose . Aprecap in combination with other antiemetic agents is indicated to prevent nausea and vomiting caused by cancer chemotherapy treatment.
Available as:

• 125 mg (1 capsule) 80 mg (2 capsules)
• Product Type : Finished Product
• Strength: 125 mg/80 mg
• Type : Cap
• Packing : 1*3
• Usage: Clinical, Hospital

We manufacture and export our brand.We also offer private labeling, Contract manufacturing service.

We Salvavidas Pharmaceutical Pvt Ltd are a leading Manufacturer and Exporter of Aprepetant capsule in different strength and packing. Our manufacturing facility is certified with WHO-GMP.
We are among the prominent manufacturers, suppliers, traders and exporters of optimum quality Aprepitant Capsules. The offered medicines are used for preventing nausea and vomiting for patients undergoing chemotherapy. Due to their fast results and high effectiveness, these drugs are highly demanded.
Composition : Aprepetant capsule 125 mg (1 capsule) 80 mg (2 capsules)

Features:

• High bio availability
• Long shelf life
• Fast results
• High effectiveness

Indication: Aprecap is also indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose . Aprecap in combination with other antiemetic agents is indicated to prevent nausea and vomiting caused by cancer chemotherapy treatment.
Available as:

• 125 mg (1 capsule) 80 mg (2 capsules)
• Product Type : Finished Product
• Strength: 125 mg/80 mg
• Type : Cap
• Packing : 1*3
• Usage: Clinical, Hospital

We manufacture and export our brand.We also offer private labeling, Contract manufacturing service.